Accuray Incorporated (ARAY)
NASDAQ: ARAY · Real-Time Price · USD
1.490
+0.010 (0.68%)
At close: Aug 13, 2025, 4:00 PM
1.470
-0.020 (-1.35%)
After-hours: Aug 13, 2025, 7:26 PM EDT
Accuray Revenue
In the fiscal year ending June 30, 2025, Accuray had annual revenue of $458.51M with 2.68% growth. Accuray had revenue of $127.54M in the quarter ending June 30, 2025, a decrease of -5.02%.
Revenue (ttm)
$458.51M
Revenue Growth
+2.68%
P/S Ratio
0.33
Revenue / Employee
$464,544
Employees
987
Market Cap
167.84M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 458.51M | 11.95M | 2.68% |
Jun 30, 2024 | 446.55M | -1.05M | -0.24% |
Jun 30, 2023 | 447.61M | 17.70M | 4.12% |
Jun 30, 2022 | 429.91M | 33.62M | 8.48% |
Jun 30, 2021 | 396.29M | 13.36M | 3.49% |
Jun 30, 2020 | Pro | Pro | Pro |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ARAY News
- 2 hours ago - Accuray Incorporated (ARAY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 hours ago - Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results - PRNewsWire
- 14 days ago - Accuray to Report Fourth Quarter Fiscal 2025 Financial Results on August 13, 2025 - PRNewsWire
- 2 months ago - Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities - PRNewsWire
- 2 months ago - Accuray to Participate in the Jefferies Global Healthcare Conference 2025 - PRNewsWire
- 3 months ago - Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025 - PRNewsWire
- 3 months ago - Accuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife® System - PRNewsWire
- 3 months ago - Accuray: Tariffs Are The Latest Obstacle For A Company That Has Struggled To Deliver (Rating Downgrade) - Seeking Alpha